CABOMETYX
NDC 42388-023, cabozantinib, tablet, from Exelixis, Inc..
- Product NDC
- 42388-023
- Status
- Listed
- Labeler
- Exelixis, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208692
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42388-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CABOZANTINIB S-MALATE60 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42388-023-26 | 42388002326 | 30 TABLET in 1 BOTTLE (42388-023-26) |
| 42388-023-36 | 42388002336 | 30 TABLET in 1 BOTTLE (42388-023-36) |
| 42388-023-37 | 42388002337 | 15 TABLET in 1 BOTTLE (42388-023-37) |
| 42388-023-46 | 42388002346 | 1 BOTTLE in 1 CARTON (42388-023-46) / 30 TABLET in 1 BOTTLE |
| 42388-023-57 | 42388002357 | 1 BOTTLE in 1 CARTON (42388-023-57) / 15 TABLET in 1 BOTTLE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3850cce2-6137-42e5-a792-d318c4a4b3b5
Use it
Look up 42388-023 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42388-023 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42388-023. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.